{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,24]],"date-time":"2026-03-24T00:48:47Z","timestamp":1774313327963,"version":"3.50.1"},"reference-count":40,"publisher":"American Diabetes Association","issue":"2","license":[{"start":{"date-parts":[[2019,1,21]],"date-time":"2019-01-21T00:00:00Z","timestamp":1548028800000},"content-version":"vor","delay-in-days":46,"URL":"http:\/\/www.diabetesjournals.org\/content\/license"}],"funder":[{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","award":["R01-DK-067561"],"award-info":[{"award-number":["R01-DK-067561"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","award":["R01-DK-098056"],"award-info":[{"award-number":["R01-DK-098056"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","award":["P30-DK-26687"],"award-info":[{"award-number":["P30-DK-26687"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","award":["P30-DK-063608"],"award-info":[{"award-number":["P30-DK-063608"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000041","name":"American Diabetes Association","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000041","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","award":["F32-DK-113747"],"award-info":[{"award-number":["F32-DK-113747"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","award":["5T32-DK-007559-22"],"award-info":[{"award-number":["5T32-DK-007559-22"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006108","name":"National Center for Advancing Translational Sciences","doi-asserted-by":"publisher","award":["UL1-TR-000040"],"award-info":[{"award-number":["UL1-TR-000040"]}],"id":[{"id":"10.13039\/100006108","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["diabetesjournals.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2019,2,1]]},"abstract":"<jats:sec>\n                  <jats:title>OBJECTIVE<\/jats:title>\n                  <jats:p>Hepatic insulin clearance is a significant regulator of glucose homestasis. We hypothesized that the improvement in insulin clearance rates (ICRs) under fasting conditions and in response to oral and intravenous (IV) glucose would improve similarly after Roux-en-Y gastric bypass (RYGB) and adjustable gastric banding (AGB) as a function of weight loss; the difference in ICR after oral and IV glucose stimulation will be enhanced after RYGB compared with AGB, an effect mediated by glucagon-like peptide 1 (GLP-1).<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>RESEARCH DESIGN AND METHODS<\/jats:title>\n                  <jats:p>In study 1, the ICR was calculated under fasting condition (F-ICR), after oral glucose (O-ICR), and after an isoglycemic IV glucose clamp (IV-ICR) in individuals from an established cohort with type 2 diabetes mellitus (T2DM) before, after 10% matched weight loss, and 1 year after either RYGB (n = 22) or AGB (n = 12). In study 2, O-ICR was studied in a separate cohort of individuals with T2DM (n = 22), before and 3 months after RYGB, with and without exendin(9-39) infusion.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>RESULTS<\/jats:title>\n                  <jats:p>In study 1, age, BMI, T2DM duration and control, and ICR did not differ between RYGB and AGB preintervention. Weight loss at 1 year was two times greater after RYGB than after AGB (31.6 \u00b1 5.9% vs. 16.6 \u00b1 9.8%; P &amp;lt; 0.05). RYGB and AGB both significantly increased F-ICR, O-ICR, and IV-ICR at 1 year. ICR was inversely associated with insulinemia. The difference between IV-ICR and O-ICR was significantly greater after RYGB versus AGB. GLP-1 antagonism with exendin(9-39) led to an increase in O-ICR in subjects post-RYGB.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>CONCLUSIONS<\/jats:title>\n                  <jats:p>Weight loss increased ICR, an effect more pronounced after RYGB compared with AGB. Our data support a potential role for endogenous GLP-1 in the control of postprandial ICR after RYGB.<\/jats:p>\n               <\/jats:sec>","DOI":"10.2337\/dc18-1036","type":"journal-article","created":{"date-parts":[[2018,12,6]],"date-time":"2018-12-06T22:17:11Z","timestamp":1544134631000},"page":"311-317","update-policy":"https:\/\/doi.org\/10.2337\/ada-journal-policies","source":"Crossref","is-referenced-by-count":27,"title":["Insulin Clearance After Oral and Intravenous Glucose Following Gastric Bypass and Gastric Banding Weight Loss"],"prefix":"10.2337","volume":"42","clinical-trial-number":[{"clinical-trial-number":"nct02287285","registry":"10.18810\/clinical-trials-gov","type":"results"}],"author":[{"given":"Ankit","family":"Shah","sequence":"first","affiliation":[{"name":"Divison of Endocrinology, Department of Medicine, Columbia University College of Physicians and Surgeons, New York, NY"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marlena M.","family":"Holter","sequence":"additional","affiliation":[{"name":"New York Obesity Nutrition Research Center, Department of Medicine, Columbia University College of Physicians and Surgeons, New York, NY"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fatima","family":"Rimawi","sequence":"additional","affiliation":[{"name":"New York Obesity Nutrition Research Center, Department of Medicine, Columbia University College of Physicians and Surgeons, New York, NY"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Victoria","family":"Mark","sequence":"additional","affiliation":[{"name":"New York Obesity Nutrition Research Center, Department of Medicine, Columbia University College of Physicians and Surgeons, New York, NY"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roxanne","family":"Dutia","sequence":"additional","affiliation":[{"name":"New York Obesity Nutrition Research Center, Department of Medicine, Columbia University College of Physicians and Surgeons, New York, NY"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James","family":"McGinty","sequence":"additional","affiliation":[{"name":"Bariatric Divsion, Department of Surgery, Mount Sinai St. Luke\u2019s, New York, NY"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bruce","family":"Levin","sequence":"additional","affiliation":[{"name":"Department of Biostatistics, Mailman School of Public Health, Columbia University, New York, NY"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8255-3175","authenticated-orcid":false,"given":"Blandine","family":"Laferr\u00e8re","sequence":"additional","affiliation":[{"name":"Divison of Endocrinology, Department of Medicine, Columbia University College of Physicians and Surgeons, New York, NY"},{"name":"New York Obesity Nutrition Research Center, Department of Medicine, Columbia University College of Physicians and Surgeons, New York, NY"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1167","published-online":{"date-parts":[[2018,12,6]]},"reference":[{"key":"2022031221343185700_B1","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1056\/NEJM199604113341504","article-title":"Hyperinsulinemia as an independent risk factor for ischemic heart disease","volume":"334","author":"Despr\u00e9s","year":"1996","journal-title":"N Engl J Med"},{"key":"2022031221343185700_B2","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1136\/jim-2016-000149","article-title":"Insulin clearance: an underappreciated modulator of plasma insulin concentration","volume":"64","author":"Kim","year":"2016","journal-title":"J Investig Med"},{"key":"2022031221343185700_B3","first-page":"E517","article-title":"Splanchnic and renal metabolism of insulin in human subjects: a dose-response study","volume":"244","author":"Ferrannini","year":"1983","journal-title":"Am J Physiol"},{"key":"2022031221343185700_B4","first-page":"E155","article-title":"Hyperinsulinemia of obesity is due to decreased clearance of insulin","volume":"245","author":"Meistas","year":"1983","journal-title":"Am J Physiol"},{"key":"2022031221343185700_B5","doi-asserted-by":"crossref","first-page":"3779","DOI":"10.2337\/dc12-1203","article-title":"Hepatic insulin clearance is closely related to metabolic syndrome components","volume":"36","author":"Pivovarova","year":"2013","journal-title":"Diabetes Care"},{"key":"2022031221343185700_B6","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1210\/jcem-63-2-492","article-title":"Incretin effects of increasing glucose loads in man calculated from venous insulin and C-peptide responses","volume":"63","author":"Nauck","year":"1986","journal-title":"J Clin Endocrinol Metab"},{"key":"2022031221343185700_B7","doi-asserted-by":"crossref","first-page":"410","DOI":"10.3109\/00365513.2012.691542","article-title":"The effect of a very low calorie diet on insulin sensitivity, beta cell function, insulin clearance, incretin hormone secretion, androgen levels and body composition in obese young women","volume":"72","author":"Svendsen","year":"2012","journal-title":"Scand J Clin Lab Invest"},{"key":"2022031221343185700_B8","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1016\/j.soard.2016.03.008","article-title":"Mechanisms of improved glucose handling after metabolic surgery: the big 6","volume":"12","author":"Paszkiewicz","year":"2016","journal-title":"Surg Obes Relat Dis"},{"key":"2022031221343185700_B9","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1002\/oby.20220","article-title":"Hepatic and peripheral insulin sensitivity do not improve 2 weeks after bariatric surgery","volume":"21","author":"de Weijer","year":"2013","journal-title":"Obesity (Silver Spring)"},{"key":"2022031221343185700_B10","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1111\/j.1463-1326.2009.01120.x","article-title":"Bariatric surgery: unstressing or boosting the \u03b2-cell","volume":"11","author":"Mingrone","year":"2009","journal-title":"Diabetes Obes Metab"},{"key":"2022031221343185700_B11","doi-asserted-by":"crossref","first-page":"1709","DOI":"10.2337\/dc06-1549","article-title":"Incretin levels and effect are markedly enhanced 1 month after Roux-en-Y gastric bypass surgery in obese patients with type 2 diabetes","volume":"30","author":"Laferr\u00e8re","year":"2007","journal-title":"Diabetes Care"},{"key":"2022031221343185700_B12","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1097\/SLA.0b013e318262ee6b","article-title":"Long-term effects of sleeve gastrectomy and Roux-en-Y gastric bypass surgery on type 2 diabetes mellitus in morbidly obese subjects","volume":"256","author":"Jim\u00e9nez","year":"2012","journal-title":"Ann Surg"},{"key":"2022031221343185700_B13","doi-asserted-by":"crossref","first-page":"7","DOI":"10.2337\/dc16-1376","article-title":"Glucose metabolism after gastric banding and gastric bypass in individuals with type 2 diabetes: weight loss effect","volume":"40","author":"Holter","year":"2017","journal-title":"Diabetes Care"},{"key":"2022031221343185700_B14","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.2337\/db13-1176","article-title":"Limited recovery of \u03b2-cell function after gastric bypass despite clinical diabetes remission","volume":"63","author":"Dutia","year":"2014","journal-title":"Diabetes"},{"key":"2022031221343185700_B15","doi-asserted-by":"crossref","first-page":"S4","DOI":"10.2337\/dc16-S003","article-title":"American Diabetes Association. Standards of Medical Care in Diabetes\u20142016: summary of revisions","volume":"39","year":"2016","journal-title":"Diabetes Care"},{"key":"2022031221343185700_B16","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1172\/JCI1349","article-title":"Exendin(9-39)amide is an antagonist of glucagon-like peptide-1(7-36)amide in humans","volume":"101","author":"Schirra","year":"1998","journal-title":"J Clin Invest"},{"key":"2022031221343185700_B17","doi-asserted-by":"crossref","first-page":"245","DOI":"10.2337\/diacare.18.2.245","article-title":"The use of areas under curves in diabetes research","volume":"18","author":"Allison","year":"1995","journal-title":"Diabetes Care"},{"key":"2022031221343185700_B18","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1007\/BF00280883","article-title":"Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man","volume":"28","author":"Matthews","year":"1985","journal-title":"Diabetologia"},{"key":"2022031221343185700_B19","doi-asserted-by":"crossref","first-page":"1462","DOI":"10.2337\/diacare.22.9.1462","article-title":"Insulin sensitivity indices obtained from oral glucose tolerance testing: comparison with the euglycemic insulin clamp","volume":"22","author":"Matsuda","year":"1999","journal-title":"Diabetes Care"},{"key":"2022031221343185700_B20","doi-asserted-by":"crossref","first-page":"368","DOI":"10.2337\/diabetes.41.3.368","article-title":"Estimation of insulin secretion rates from C-peptide levels. Comparison of individual and standard kinetic parameters for C-peptide clearance","volume":"41","author":"Van Cauter","year":"1992","journal-title":"Diabetes"},{"key":"2022031221343185700_B21","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1007\/s00125-017-4511-0","article-title":"Adapting to insulin resistance in obesity: role of insulin secretion and clearance","volume":"61","author":"Jung","year":"2018","journal-title":"Diabetologia"},{"key":"2022031221343185700_B22","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1038\/ijo.2017.22","article-title":"Changes in glycemia, insulin and gut hormone responses to a slowly ingested solid low-carbohydrate mixed meal after laparoscopic gastric bypass or band surgery","volume":"41","author":"Bunt","year":"2017","journal-title":"Int J Obes"},{"key":"2022031221343185700_B23","doi-asserted-by":"crossref","first-page":"E1066","DOI":"10.1210\/jc.2013-1286","article-title":"Increased hepatic insulin clearance after Roux-en-Y gastric bypass","volume":"98","author":"Bojsen-M\u00f8ller","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"key":"2022031221343185700_B24","doi-asserted-by":"crossref","first-page":"3027","DOI":"10.2337\/db12-1762","article-title":"Very low-calorie diet mimics the early beneficial effect of Roux-en-Y gastric bypass on insulin sensitivity and \u03b2-cell function in type 2 diabetic patients","volume":"62","author":"Jackness","year":"2013","journal-title":"Diabetes"},{"key":"2022031221343185700_B25","doi-asserted-by":"crossref","first-page":"E1709","DOI":"10.1152\/ajpendo.00444.2007","article-title":"Effect of liver fat on insulin clearance","volume":"293","author":"Kotronen","year":"2007","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"2022031221343185700_B26","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1097\/SLA.0000000000000945","article-title":"Roux-en-Y gastric bypass versus adjustable gastric banding to reduce nonalcoholic fatty liver disease: a 5-year controlled longitudinal study","volume":"260","author":"Caiazzo","year":"2014","journal-title":"Ann Surg"},{"key":"2022031221343185700_B27","doi-asserted-by":"crossref","first-page":"E59","DOI":"10.1152\/ajpendo.00559.2012","article-title":"Nutrient infusion bypassing duodenum-jejunum improves insulin sensitivity in glucose-tolerant and diabetic obese subjects","volume":"305","author":"Salinari","year":"2013","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"2022031221343185700_B28","doi-asserted-by":"crossref","first-page":"2178","DOI":"10.1002\/hep.26988","article-title":"Relationship between disease severity, hyperinsulinemia, and impaired insulin clearance in patients with nonalcoholic steatohepatitis","volume":"59","author":"Bril","year":"2014","journal-title":"Hepatology"},{"key":"2022031221343185700_B29","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1007\/s00125-013-3134-3","article-title":"Pancreatic beta cell function following liraglutide-augmented weight loss in individuals with prediabetes: analysis of a randomised, placebo-controlled study","volume":"57","author":"Kim","year":"2014","journal-title":"Diabetologia"},{"key":"2022031221343185700_B30","doi-asserted-by":"crossref","first-page":"2140","DOI":"10.1007\/s00125-005-1915-z","article-title":"Reduced insulin clearance contributes to the increased insulin levels after administration of glucagon-like peptide 1 in mice","volume":"48","author":"Ahr\u00e9n","year":"2005","journal-title":"Diabetologia"},{"key":"2022031221343185700_B31","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1016\/j.metabol.2009.10.021","article-title":"Dissociated effects of glucose-dependent insulinotropic polypeptide vs glucagon-like peptide-1 on beta-cell secretion and insulin clearance in mice","volume":"59","author":"Pacini","year":"2010","journal-title":"Metabolism"},{"key":"2022031221343185700_B32","doi-asserted-by":"crossref","first-page":"E849","DOI":"10.1152\/ajpendo.00289.2007","article-title":"Reduction of hepatic insulin clearance after oral glucose ingestion is not mediated by glucagon-like peptide 1 or gastric inhibitory polypeptide in humans","volume":"293","author":"Meier","year":"2007","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"2022031221343185700_B33","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1210\/endo-115-3-1011","article-title":"The hepatic extraction of gastric inhibitory polypeptide and insulin","volume":"115","author":"Hanks","year":"1984","journal-title":"Endocrinology"},{"key":"2022031221343185700_B34","first-page":"2015","article-title":"Glucose-dependent insulinotropic hormone potentiates the hypoglycemic effect of glibenclamide in healthy volunteers: evidence for an effect on insulin extraction","volume":"86","author":"Kindmark","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"key":"2022031221343185700_B35","doi-asserted-by":"crossref","first-page":"2359","DOI":"10.2337\/diabetes.53.9.2359","article-title":"Reduced hepatic insulin extraction in response to gastric inhibitory polypeptide compensates for reduced insulin secretion in normal-weight and normal glucose tolerant first-degree relatives of type 2 diabetic patients","volume":"53","author":"Rudovich","year":"2004","journal-title":"Diabetes"},{"key":"2022031221343185700_B36","doi-asserted-by":"crossref","first-page":"505","DOI":"10.3109\/00365518609083705","article-title":"Relationship between changes in GIP concentrations and changes in insulin and C-peptide concentrations after guar gum therapy","volume":"46","author":"Groop","year":"1986","journal-title":"Scand J Clin Lab Invest"},{"key":"2022031221343185700_B37","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1038\/ijo.2015.250","article-title":"Temporal changes in bile acid levels and 12\u03b1-hydroxylation after Roux-en-Y gastric bypass surgery in type 2 diabetes","volume":"40","author":"Dutia","year":"2016","journal-title":"Int J Obes"},{"key":"2022031221343185700_B38","doi-asserted-by":"crossref","first-page":"42","DOI":"10.2337\/dc11-1472","article-title":"Magnitude and variability of the glucagon-like peptide-1 response in patients with type 2 diabetes up to 2 years following gastric bypass surgery","volume":"35","author":"Van der Schueren","year":"2012","journal-title":"Diabetes Care"},{"key":"2022031221343185700_B39","doi-asserted-by":"crossref","first-page":"2008","DOI":"10.1210\/jc.2013-2686","article-title":"Altered islet function and insulin clearance cause hyperinsulinemia in gastric bypass patients with symptoms of postprandial hypoglycemia","volume":"99","author":"Salehi","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"key":"2022031221343185700_B40","doi-asserted-by":"crossref","first-page":"2016","DOI":"10.1172\/JCI107386","article-title":"Effect of intraduodenal glucose administration on hepatic extraction of insulin in the anesthetized dog","volume":"52","author":"Kaden","year":"1973","journal-title":"J Clin Invest"}],"container-title":["Diabetes Care"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/care.diabetesjournals.org\/syndication\/doi\/10.2337\/dc18-1036","content-type":"unspecified","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/diabetesjournals.org\/care\/article-pdf\/42\/2\/311\/527317\/dc181036.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/diabetesjournals.org\/care\/article-pdf\/42\/2\/311\/527317\/dc181036.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,12]],"date-time":"2022-03-12T23:52:10Z","timestamp":1647129130000},"score":1,"resource":{"primary":{"URL":"https:\/\/diabetesjournals.org\/care\/article\/42\/2\/311\/30498\/Insulin-Clearance-After-Oral-and-Intravenous"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,12,6]]},"references-count":40,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2018,12,6]]},"published-print":{"date-parts":[[2019,2,1]]}},"URL":"https:\/\/doi.org\/10.2337\/dc18-1036","relation":{},"ISSN":["0149-5992","1935-5548"],"issn-type":[{"value":"0149-5992","type":"print"},{"value":"1935-5548","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,12,6]]}}}